Literature DB >> 12023535

Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.

Jan Jakubík1, Stanislav Tucek, Esam E El-Fakahany.   

Abstract

Xanomeline is a potent agonist that is functionally selective for muscarinic M(1) receptors. We have shown previously that a significant fraction of xanomeline binding to membranes of Chinese hamster ovary (CHO) cells expressing the M(1) receptors occurs in a wash-resistant manner and speculated that this persistent binding likely does not take place at the primary binding site on the receptor. In the present work we investigated in depth the pharmacological characteristics of this unique mode of xanomeline binding and the effects of this binding on the interaction of classical competitive ligands with the receptor in CHO cells that express the M(1) muscarinic receptor. Onset of persistent binding of xanomeline to the M(1) muscarinic receptor was fast and was only slightly hindered by atropine. Its dissociation was extremely slow, with a half-life of over 30 h. Although persistently bound xanomeline strongly inhibited binding of the classical antagonist N-methylscopolamine (NMS) to the receptor, there are multiple indications that this is not the result of competition at the same binding domain. Namely, wash-resistant binding of xanomeline only slightly slowed the rate of NMS association, but enhanced the rate of NMS dissociation. Moreover, preincubation with xanomeline followed by extensive washing brought about an apparent decrease in the number of NMS binding sites. Our findings are best interpreted in terms of allosteric interactions between xanomeline-persistent binding to the M(1) muscarinic receptor and competitive ligands bound to the classical receptor binding site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023535     DOI: 10.1124/jpet.301.3.1033

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.

Authors:  Kayla C De Lorme; Krista L Sikorski; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurosci Lett       Date:  2006-10-18       Impact factor: 3.046

3.  Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways.

Authors:  Pavel Michal; Vladimír Rudajev; Esam E El-Fakahany; Vladimír Dolezal
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

4.  Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurochem Res       Date:  2008-12-12       Impact factor: 3.996

5.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

6.  Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.

Authors:  Marianne K O Grant; Meredith J Noetzel; Kayla C De Lorme; Jan Jakubík; Vladimír Doležal; Esam E El-Fakahany
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

7.  Novel long-acting antagonists of muscarinic ACh receptors.

Authors:  Alena Randáková; Vladimír Rudajev; Vladimír Doležal; John Boulos; Jan Jakubík
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

8.  Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.

Authors:  Christopher N Davis; Stefania Risso Bradley; Hans H Schiffer; Mikael Friberg; Kristian Koch; Bo-Ragnar Tolf; Douglas W Bonhaus; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2009-12-02

9.  Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity.

Authors:  Laurence Desrues; Thomas Lefebvre; Céline Lecointre; Marie-Thérèse Schouft; Jérôme Leprince; Vincent Compère; Fabrice Morin; François Proust; Pierrick Gandolfo; Marie-Christine Tonon; Hélène Castel
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

10.  Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.

Authors:  Eva Šantrůčková; Vladimír Doležal; Esam E El-Fakahany; Jan Jakubík
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.